Loading...
XLON
BVC
Market cap97mUSD
May 20, Last price  
16.68GBP
1D
0.30%
1Q
-7.08%
Jan 2017
-10.44%
Name

Batm Advanced Communications Ltd

Chart & Performance

D1W1MN
P/E
P/S
79.39
EPS
Div Yield, %
Shrs. gr., 5y
1.46%
Rev. gr., 5y
0.54%
Revenues
123m
+5.78%
41,218,00056,514,00073,472,00096,952,000134,462,080135,394,355120,577,688127,633,570107,774,000114,155,000109,247,00097,096,00090,404,000107,137,000119,561,000123,396,000183,566,000140,038,000116,123,000122,830,000
Net income
-193k
L
-12,781,000-3,423,0006,445,00019,874,00024,204,66120,516,8441,698,7840713,000-4,513,000-3,176,000-13,250,000-1,070,000233,000585,0003,917,0009,793,00014,340,0001,556,000-193,000
CFO
5m
P
-1,924,000-3,213,0003,776,00012,644,0009,093,33520,233,88612,481,7603,137,7273,206,000634,000-5,282,000-2,247,000915,00056,0002,607,0007,166,00018,459,0005,592,000-2,784,0005,009,000
Dividend
Dec 09, 20210.74 GBP/sh

Profile

BATM Advanced Communications Ltd., together with its subsidiaries, develops, produces, and markets real-time technologies in Israel, the United States, and Europe. It operates through two segments, Networking and Cyber, and Bio-Medical. The Networking and Cyber segment is involved in the research and development, production, and marketing of data communication products, including network function virtualization, edge computing, carrier ethernet and MPLS access solutions, cyber network monitoring, and network encryption. This segment also offers software services, such as training and technical support, laboratory service and maintenance; and construction contracts. The Bio-Medical segment offers molecular biology diagnostics; and solutions to treat pathogenic and medical waste in laboratories and hospitals, as well as for pharmaceutical manufacturing plants and agricultural applications. This segment also administers testing services; and distributes diagnostic equipment and medical supplies of various brands. The company was incorporated in 1992 and is headquartered in Hod Hasharon, Israel.
IPO date
Aug 12, 1996
Employees
949
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
122,830
5.78%
116,123
-17.08%
Cost of revenue
123,482
115,417
Unusual Expense (Income)
NOPBT
(652)
706
NOPBT Margin
0.61%
Operating Taxes
839
339
Tax Rate
48.02%
NOPAT
(1,491)
367
Net income
(193)
-112.40%
1,556
-89.15%
Dividends
(4,300)
Dividend yield
3.55%
Proceeds from repurchase of equity
(1,325)
BB yield
1.09%
Debt
Debt current
5,106
4,219
Long-term debt
8,458
11,500
Deferred revenue
Other long-term liabilities
4,047
4,009
Net debt
(46,314)
(36,212)
Cash flow
Cash from operating activities
5,009
(2,784)
CAPEX
(2,404)
(4,468)
Cash from investing activities
(6,120)
(16,342)
Cash from financing activities
(2,160)
(7,050)
FCF
224
(13,347)
Balance
Cash
40,764
44,167
Long term investments
19,114
7,764
Excess cash
53,736
46,125
Stockholders' equity
(249,490)
(279,325)
Invested Capital
382,057
406,494
ROIC
0.09%
ROCE
0.55%
EV
Common stock shares outstanding
436,818
442,357
Price
0.20
-26.09%
0.27
-67.42%
Market cap
88,456
-27.02%
121,206
-67.56%
EV
71,099
116,740
EBITDA
4,524
5,597
EV/EBITDA
15.72
20.86
Interest
1,374
2,011
Interest/NOPBT
284.84%